Guidance for industry : supplemental testing and the notification of consignees of donor test results for antibody to hepatitis C virus (anti-HCV).

Other author Center for Biologics Evaluation and Research (U.S.)
Format Electronic
Publication InfoRockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [1998]
Description8 p. : digital, PDF file
Supplemental Contenthttps://purl.fdlp.gov/GPO/LPS113572
Subjects

Portion of title Supplemental testing and the notification of consignees of donor test results for antibody to hepatitis C virus (anti-HCV)
General noteTitle from PDF title page (viewed on June 8, 2009).
General note"March 1998".
General noteGPO Cataloging Record Distribution Program (CRDP).
Bibliography noteIncludes bibliographical references (p. 8).
Technical detailsMode of access: Internet at the FDA web site. Address as of 6/8/09: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm080834.pdf ; current access is available via PURL.
GPO item number0499-T-02 (online)
Govt. docs number HE 20.4802:T 28

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available